Literature DB >> 1547285

Branched chain acyltransferase absence due to an Alu-based genomic deletion allele and an exon skipping allele in a compound heterozygote proband expressing maple syrup urine disease.

W J Herring1, M McKean, N Dracopoli, D J Danner.   

Abstract

Branched chain alpha-ketoacid dehydrogenase assembles around a core of the acyltransferase components on the matrix side of the mitochondrial inner membrane. Autosomal recessive mutations in humans are known to decrease the function of this complex resulting in the clinical phenotype of maple syrup urine disease. Within this wide group of mutations are a subset which result in the antigenic absence of the acyltransferase protein of the complex. Here we describe two mutations in a compound heterozygote proband which result in this acyltransferase-negative phenotype. The mutant allele inherited from the father lacks 15-20 kilobases of genomic DNA resulting from a recombinational event between an intronic Alu sequence and coding sequence in the terminal exon. The mother's mutant allele contains a single base substitution in the -1 position of the 5' splice junction following exon 8. This G1002----A transition results in exon skipping producing two different mRNAs. The first lacks only exon 8 while the second lacks exons 8-10. All mRNAs for the acyltransferase found in cells from the proband have the potential to produce proteins ranging in size from 251-395 amino acids, the largest being 26 amino acids short of a full-length acyltransferase. The potential of these transcripts to produce protein is of interest since the patient is clinically responsive to pharmacologic treatment with thiamin, showing a higher tolerance to protein in the diet. The mechanism for this thiamin response remains to be explained.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1547285     DOI: 10.1016/0925-4439(92)90043-m

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Maple syrup urine disease 1954 to 1993.

Authors:  F Peinemann; D J Danner
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

2.  E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.

Authors:  J L Chuang; R P Cox; D T Chuang
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

3.  Gene preference in maple syrup urine disease.

Authors:  M M Nellis; D J Danner
Journal:  Am J Hum Genet       Date:  2000-12-07       Impact factor: 11.025

4.  Abnormal muscle development in the heldup3 mutant of Drosophila melanogaster is caused by a splicing defect affecting selected troponin I isoforms.

Authors:  J A Barbas; J Galceran; L Torroja; A Prado; A Ferrús
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

5.  Maple syrup urine disease (MSUD): screening for known mutations in Italian patients.

Authors:  T Parrella; S Surrey; A Iolascon; M Sartore; R Heidenreich; G Diamond; A Ponzone; O Guardamagna; A B Burlina; R Cerone
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

6.  Mutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease.

Authors:  Timo Friedrich; Aaron M Lambert; Mark A Masino; Gerald B Downes
Journal:  Dis Model Mech       Date:  2011-11-01       Impact factor: 5.758

7.  Maple syrup urine disease: new insights from a zebrafish model.

Authors:  Nathan B Roberts
Journal:  Dis Model Mech       Date:  2012-07       Impact factor: 5.758

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.